Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

About this update from Tempus Ai, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/f13284835a426f9d55648d4944d380a5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tarvrgaPSMWYoqAI1KKSJA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/f13284835a426f9d55648d4944d380a5","width":960,"height":480},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/sEsTSyd9o41AXvj.TWDjYQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/business-wire.com/f13284835a426f9d55648d4944d380a5","width":640,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/t2Tk_njGNiRWVC19qjjHlQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/f13284835a426f9d55648d4944d380a5","width":1024,"height":512}},"lazy":false},{"type":"text","content":"CHICAGO, May 27, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a major technological upgrade to Tempus Hub, its AI-enabled smart physician platform. Tempus is making available its advanced, next-generation generative AI clinical co-pilot directly in Hub to power an agent-first experience for healthcare providers, allowing them to integrate the benefits of large language models and generative AI capabilities with their diagnostic results to better treat cancer patients","length":575,"tagName":"p"},{"type":"text","content":"This upgrade connects Tempus’ most advanced agentic AI capabilities directly with real-time patient data inside the Hub environment, scaling how providers utilize, interpret, and act upon complex diagnostic insights. Trusted by thousands of oncologists and care teams, Hub is a secure, AI-enabled platform that delivers actionable patient insights at the point of care. The platform provides seamless access to Tempus test orders and results, including guideline-matched therapies, treatment resistance insights, clinical trial opportunities, and longitudinal biomarker tracking for every patient.","length":597,"tagName":"p"},{"type":"text","content":"This new architecture introduces an advanced layer of agentic AI-enabled proactive intelligence. Key features rolling out to users includ...

More updates from Tempus Ai, Inc.